Magenta Therapeutics Inc

Market cap: $46,651,152

Exchange: NAS

Sector: Health Technology

Share
Tweet

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers platform that focuses on critical areas of transplant medicine. The company was founded by David Scadden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, MA.

Key Statistics

Company Name

Magenta Therapeutics Inc

Average Volume (10 days)

123,385

Average Volume (30 days)

225,190

Moving Average (50 days)

$0.7909

Moving Average (200 days)

$0.7541

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

46,651,152

Shares Outstanding

60,664,697

52-Week High Split Adjust Only

2.22

52-Week Low Split Adjust Only

0.321

Employee Count

81

Beta

0.405

Next Earnings Date

2023-11-02

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.01%

Past 30 days

-0.05%

Past 3 months

0.21%

Past 6 months

-0.05%

Past year

-0.54%

Past 2 years

-0.88%

Past 5 years

-0.95%

Max % Change

-0.95%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Magenta Therapeutics IncMGTAn/an/a-8.7n/an/a
Peer AvgN/An/an/a-1.9n/an/a
Omega Therapeutics IncOMGAn/an/an/an/an/a
Oncorus IncONCRn/an/a-7.4n/an/a